These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15158017)

  • 1. Cholecystokinin and prostaglandins inhibit responses of vagal afferent activity to systemic administration of nicotine in anesthetized rats.
    Kurosawa M; Taniguchi T; Yoneda M
    Neurosci Lett; 2004 May; 362(3):213-5. PubMed ID: 15158017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway.
    Glatzle J; Darcel N; Rechs AJ; Kalogeris TJ; Tso P; Raybould HE
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R354-9. PubMed ID: 15117731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats.
    Ogawa N; Yamaguchi H; Shimbara T; Toshinai K; Kakutani M; Yonemori F; Nakazato M
    Neurosci Lett; 2008 Mar; 433(1):38-42. PubMed ID: 18248897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indomethacin on nicotine-induced ACTH and corticosterone response.
    Bugajski J; Gadek-Michalska A; Borycz J; Głód R
    J Physiol Pharmacol; 1998 Mar; 49(1):165-73. PubMed ID: 9594419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the gastric vagal afferent activity to cholecystokinin in rats lacking type A cholecystokinin receptors.
    Kurosawa M; Bucinskaite V; Taniguchi T; Miyasaka K; Funakoshi A; Lundeberg T
    J Auton Nerv Syst; 1999 Jan; 75(1):51-9. PubMed ID: 9935269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepato-vagal pathway associated with nicotine's anorectic effect in the rat.
    Niijima A; Miyata G; Sato T; Meguid MM
    Auton Neurosci; 2001 Oct; 93(1-2):48-55. PubMed ID: 11695706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
    Mussa BM; Sartor DM; Verberne AJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
    Gourcerol G; Million M; Adelson DW; Wang Y; Wang L; Rivier J; St-Pierre DH; Taché Y
    Peptides; 2006 Nov; 27(11):2811-9. PubMed ID: 16934368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin.
    Cox JE; Kelm GR; Meller ST; Randich A
    Physiol Behav; 2004 Aug; 82(1):27-33. PubMed ID: 15234586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric vagal efferent inhibition evoked by intravenous CRF is unrelated to simultaneously recorded vagal afferent activity in urethane-anesthetized rats.
    Adelson DW; Kosoyan HP; Wang Y; Steinberg JZ; Taché Y
    J Neurophysiol; 2007 Apr; 97(4):3004-14. PubMed ID: 17314242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in afferent signal transduction in the rat.
    Richards W; Hillsley K; Eastwood C; Grundy D
    J Physiol; 1996 Dec; 497 ( Pt 2)(Pt 2):473-81. PubMed ID: 8961188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat.
    Glatzle J; Wang Y; Adelson DW; Kalogeris TJ; Zittel TT; Tso P; Wei JY; Raybould HE
    J Physiol; 2003 Jul; 550(Pt 2):657-64. PubMed ID: 12766241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of peripheral and central nicotinic receptors in the micturition reflex in rats.
    Masuda H; Hayashi Y; Chancellor MB; Kihara K; de Groat WC; de Miguel F; Yoshimura N
    J Urol; 2006 Jul; 176(1):374-9. PubMed ID: 16753446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
    Peters JH; Simasko SM; Ritter RC
    Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents.
    Hillsley K; Grundy D
    Neurosci Lett; 1998 Oct; 255(2):63-6. PubMed ID: 9835215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin.
    Peters JH; Karpiel AB; Ritter RC; Simasko SM
    Endocrinology; 2004 Aug; 145(8):3652-7. PubMed ID: 15105382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents.
    Schwartz GJ; McHugh PR; Moran TH
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R303-8. PubMed ID: 8048636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intraperitoneal administration of leptin on short-term food intake in rats.
    Patel JD; Ebenezer IS
    Eur J Pharmacol; 2008 Feb; 580(1-2):143-52. PubMed ID: 18031736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents.
    Schwartz GJ; McHugh PR; Moran TH
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R872-6. PubMed ID: 8238459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.